PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel.\', \'Institute of Oncology, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel. evensap@tlvmc.gov.il.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. evensap@tlvmc.gov.il.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00259-021-05579-7
?:doi
?:hasPublicationType
?:journal
  • European journal of nuclear medicine and molecular imaging
is ?:pmid of
?:pmid
?:pmid
  • 34651230
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.458
?:rankingScore_hIndex
  • 148
?:title
  • A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [18F]FDG PET-CT studies performed in oncologic patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all